Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody

Katrine E Dailey, Yiquan Wang, Qi Wen Teo, Chaoyang Wang, Huibin Lv, Ruipeng Lei, Meixuan Tong, Lucia A Rodriguez, Letianchu Wang, Nicholas C Wu, Harmit S Malik · 2026

Read Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody by Katrine E Dailey, Yiquan Wang, Qi Wen Teo, Chaoyang Wang, Huibin Lv, Ruipeng Lei, Meixuan Tong, Lucia A Rodriguez, Letianchu Wang, Nicholas C Wu, Harmit S Malik (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13638050.txt.

Description

Katrine E Dailey and ten colleagues investigate why almost no flu antibody manages to neutralize both influenza A and influenza B. The stem of the virus's surface protein barely changes, making it the prime target for a universal vaccine strategy. One famous antibody, CR9114, crosses the A-B divide alone. The team ran four deep mutational scans, testing thousands of variants of the antibody's ancestor and its mature form against three viral targets.

The trade-offs were stark. Many changes that kept or even improved binding to one influenza A subtype damaged binding to the other subtype or to influenza B. Mutations also interacted with each other pervasively, so gains could not simply be stacked. Together these constraints explain the scarcity of cross-reactive stem antibodies on mechanistic grounds. Vaccine designers chasing breadth, the authors argue, must engineer around epistasis rather than optimize one target at a time.

Catalog record

CREATORKatrine E Dailey, Yiquan Wang, Qi Wen Teo, Chaoyang Wang, Huibin Lv, Ruipeng Lei, Meixuan Tong, Lucia A Rodriguez, Letianchu Wang, Nicholas C Wu, Harmit S Malik
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13638050

Browse the full library · About the Tower of Babel